Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $104

Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $100 to $104.

byBenzinga Newsdesk

October 25, 2022

1 minute read

Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $100 to $104.

What CNBC’s ‘Final Trades’ Says About Home Depot, Lamar Advertising, Newmont And This Leading Automaker

By Priya Nigam

Today, 5:23 AM

On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said Home Depot Inc (NYSE: HD) had a tough year in 2022.

Societe Generale Downgrades ConocoPhillips to Sell, Raises Price Target to $114

By Benzinga Newsdesk

Today, 5:23 AM

Societe Generale analyst Raphael Dubois downgrades ConocoPhillips (NYSE:COP) from Hold to Sell and raises the price target from $106 to $114.

COP

Nirvana Wholesale To Distribute Sipp Industries’ Major Hemp Delta-8 Beverages

By Vuk Zdinjak

Today, 5:23 AM

Sipp Industries, Inc. (OTC: SIPC) has come to terms with Nirvana Wholesale, to distribute a new line of Delta-8 infused beverages under the legacy Major Hemp brand.

SIPC

Deutsche Bank Maintains Hold on Edwards Lifesciences, Raises Price Target to $113

By Benzinga Newsdesk

Today, 5:23 AM

Deutsche Bank analyst Pito Chickering maintains Edwards Lifesciences (NYSE:EW) with a Hold and raises the price target from $84 to $113.

Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $104

Related Posts

What CNBC’s ‘Final Trades’ Says About Home Depot, Lamar Advertising, Newmont And This Leading Automaker

Societe Generale Downgrades ConocoPhillips to Sell, Raises Price Target to $114

Nirvana Wholesale To Distribute Sipp Industries’ Major Hemp Delta-8 Beverages

Deutsche Bank Maintains Hold on Edwards Lifesciences, Raises Price Target to $113